[ Price : $8.95]
FDA commissioner Marty Makary says the agency is exploring the use of a new drug approval pathway for rare diseases and incurable ...[ Price : $8.95]
An FDA Matters blog post analyzes a leaked document purporting to show a 17% decrease in FDA budget authority spending for FY 2026...[ Price : $8.95]
Two reports highlight U.S. dependence on foreign sources for APIs and finished drugs and call for urgent steps to reduce that depe...[ Price : $8.95]
FDA commissioner Marty Makary announces a new policy directive that limits those employed at regulated industries from serving as ...[ Price : $8.95]
Federal Register notice: FDA reschedules a previously planned drug safety advisory committee involving opioid overdose risk studie...[ Price : $8.95]
A report on the 2024 Global Summit on Regulatory Science calls for a collaborative global effort to harness artificial intelligenc...[ Price : $8.95]
Three FDA staffers discuss the agencys efforts to advance the use of digital health technologies in clinical trials.[ Price : $8.95]
Recent FDA layoffs raise concerns across the drug and biologic industries as experts warn that diminished inspection capacity coul...